Current Medical Research and Opinion · 1979 · 24 citations · 3 references
MedicinePharmacologyPharmacotherapyMaternal-fetal MedicineObstetric ComplicationsParenteral Dosage FormsMaternal Medical Complications In PregnancyPregnancyPregnancy PharmacologyDrug Dosing In PregnancyDrug Metabolism In PregnancyDrug Monitoring During PregnancyIntrauterine Growth RetardationPharmaceutical Exposure During PregnancyPharmacotherapy In PregnancyPregnancy Drug Exposure
Disopyramide (200 mg 8-hourly) was given to a pregnant patient from the 26th week onwards for the treatment of bigeminy and paroxysmal ventricular tachycardia. Labour was spontaneous and normal. Although disopyramide was demonstrated in the foetal blood there was no evidence of congenital abnormality or growth retardation. The drug treated the mother satisfactorily with no apparent ill effects to the child.
3
R.C. Heel, Rex N. Brogden, T.M. Speight et al. · Drugs · 1978 · 118 citations
Pharmacy, Cardiology, Pharmacology +11
R A Spurrell, Charles W. Thorburn, E Sowton et al. · Heart · 1975 · 102 citations · Full text
Medicine, Cardiology, Pharmacology +17
[Pharmacology and toxicology of disopyramide].
R Jequier, R. Deraedt, R Plongeron et al. · PubMed · 1970 · 16 citations